Literature DB >> 8550188

Identification of murine protective epitopes on the Porphyromonas gingivalis fimbrillin molecule.

M Deslauriers1, S Haque, P M Flood.   

Abstract

Fimbriae from Porphyromonas gingivalis are believed to play an important role in the pathogenesis of periodontal diseases. The aim of the present study was to identify the fimbrial protective T-cell epitopes in CBA/J mice. A truncated protein corresponding to amino acids 1 to 198, PgF1-198, was generated and allowed us to demonstrate that the N terminus of the protein contains T-cell epitopes. With synthetic peptides, an immunodominant sequence was identified between amino acids 103 and 122. The corresponding peptide, PgF-P8, induced T-cell proliferation after in vitro restimulation of in vivo-primed cells, giving a stimulation index comparable to the one obtained with r-fimbrillin, and induced production of both Th1 and Th2 cytokines. Growth supernatant contained significant levels of interleukin 2 (IL-2), gamma interferon, IL-4 (28 pg/ml), and tumor necrosis factor alpha. Immunization of mice with r-fimbrillin, PgF1-198, and PgF-P8 induced production of antibodies specific to r-fimbrillin and PgF-P8. In addition, by using the mouse chamber model we found that mice immunized with PgF-P8 were dramatically protected against a normally lethal injection of P. gingivalis. Animals immunized with PgF-P8 40 days prior to challenge showed a 60% survival rate when challenged with P. gingivalis, compared with just 25% survival in control animals and just 5% survival in mice immunized with PgF-P8 only 21 days prior to challenge. Although the protection depended on the time of immunization before the bacterial challenge, it did not correlate with in vivo local cytokine production (IL-2, IL-4, IL-6, tumor necrosis factor alpha, and gamma interferon), specific antibody levels, or the isotype of anti-PgF-P8 antibodies produced.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8550188      PMCID: PMC173782          DOI: 10.1128/iai.64.2.434-440.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Sequence analysis of peptides bound to MHC class II molecules.

Authors:  A Rudensky; P Preston-Hurlburt; S C Hong; A Barlow; C A Janeway
Journal:  Nature       Date:  1991-10-17       Impact factor: 49.962

2.  Immunobiological activities of synthetic peptide segments of fimbrial protein from Porphyromonas gingivalis.

Authors:  T Ogawa; Y Kusumoto; H Uchida; S Nagashima; H Ogo; S Hamada
Journal:  Biochem Biophys Res Commun       Date:  1991-11-14       Impact factor: 3.575

3.  Evidence that Porphyromonas (Bacteroides) gingivalis fimbriae function in adhesion to Actinomyces viscosus.

Authors:  P A Goulbourne; R P Ellen
Journal:  J Bacteriol       Date:  1991-09       Impact factor: 3.490

4.  Cytokine serum level during severe sepsis in human IL-6 as a marker of severity.

Authors:  P Damas; D Ledoux; M Nys; Y Vrindts; D De Groote; P Franchimont; M Lamy
Journal:  Ann Surg       Date:  1992-04       Impact factor: 12.969

5.  A novel mouse model to study the virulence of and host response to Porphyromonas (Bacteroides) gingivalis.

Authors:  C A Genco; C W Cutler; D Kapczynski; K Maloney; R R Arnold
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

6.  Porphyromonas gingivalis-specific serum IgG and IgA antibodies originate from immunoglobulin-secreting cells in inflamed gingiva.

Authors:  T Ogawa; Y Kono; M L McGhee; J R McGhee; J E Roberts; S Hamada; H Kiyono
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

7.  Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humans.

Authors:  A S Dofferhoff; V J Bom; H G de Vries-Hospers; J van Ingen; J vd Meer; B P Hazenberg; P O Mulder; J Weits
Journal:  Crit Care Med       Date:  1992-02       Impact factor: 7.598

8.  Synthetic peptides analogous to the fimbrillin sequence inhibit adherence of Porphyromonas gingivalis.

Authors:  J Y Lee; H T Sojar; G S Bedi; R J Genco
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

9.  Tumor necrosis factor alone does not explain the lethal effect of lipopolysaccharide.

Authors:  L Sánchez-Cantú; H N Rode; T J Yun; N V Christou
Journal:  Arch Surg       Date:  1991-02

10.  Influence of immunization on Porphyromonas gingivalis colonization and invasion in the mouse chamber model.

Authors:  C A Genco; D R Kapczynski; C W Cutler; R J Arko; R R Arnold
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

View more
  5 in total

1.  RgpA-Kgp peptide-based immunogens provide protection against Porphyromonas gingivalis challenge in a murine lesion model.

Authors:  N M O'Brien-Simpson; R A Paolini; E C Reynolds
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

2.  Expression of functional Porphyromonas gingivalis fimbrillin polypeptide domains on the surface of Streptococcus gordonii.

Authors:  A Sharma; H Nagata; N Hamada; H T Sojar; D E Hruby; H K Kuramitsu; R J Genco
Journal:  Appl Environ Microbiol       Date:  1996-11       Impact factor: 4.792

3.  Oral immunization with recombinant Streptococcus gordonii expressing porphyromonas gingivalis FimA domains.

Authors:  A Sharma; K Honma; R T Evans; D E Hruby; R J Genco
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

4.  Distribution and molecular characterization of Porphyromonas gingivalis carrying a new type of fimA gene.

Authors:  I Nakagawa; A Amano; R K Kimura; T Nakamura; S Kawabata; S Hamada
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

Review 5.  Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis.

Authors:  R J Lamont; H F Jenkinson
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.